Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Naithani

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Indian Journal of Pediatrics|May 29, 2007
Rubella infection with autoimmune hemolytic anemiaNeerja Agrawal, Rahul Naithani, M Mahapatra
Hematology, Transfusion and Cell Therapy|September 27, 2024
Bortezomib and low dose venetoclax therapy for relapsed/refractory B-cell acute lymphoblastic leukemia with IDH1 mutationPronamee Borah, Ayoniza Maitri, Rahul Naithani
Journal of Pediatric Hematology/Oncology|October 23, 2015
Successful Use of Eltrombopag in a Child With Hurler Syndrome After Haploidentical Hematopoietic Stem Cell TransplantationRahul Naithani, Mansi Sachdev, Rajiv Uttam
Indian Journal of Pediatrics|May 5, 2009
Pseudotumor cerebri in a child in early phase of induction therapy for APL with ATRARahul Naithani, Rajat Kumar, Pravas Mishra
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 22, 2017
Single Versus Dual Platform Analysis for Hematopoietic Stem Cell Enumeration Using ISHAGE ProtocolRahul Naithani, Nitin Dayal, Gaurav Dixit
South Asian Journal of Cancer|June 17, 2021
Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple MyelomaRahul Naithani, Nitin Dayal, Reeta Rai
Pediatric Blood & Cancer|July 2, 2024
Low-dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe-BIRD) in a child with relapsed/refractory B-cell acute lymphoblastic leukemia with TP53 mutationVivek Mohan, Sachin Jain, Rahul Naithani
European Journal of Haematology|February 8, 2005
Safety of oral iron chelator deferiprone in young thalassaemicsRahul Naithani, Jagdish Chandra, Sharad Sharma
Pediatric Blood & Cancer|February 9, 2008
Does familial predisposition exist in idiopathic thrombocytopenic purpura?Rahul Naithani, Rajat Kumar, M Mahapatra
Pediatric Blood & Cancer|January 6, 2016
T-Cell Acute Lymphoblastic Leukemia, Minimal Residual Disease, and Lymphocyte RecoveryRahul Naithani, Mohammad Abdelhaleem, Angela Punnett
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Indian Journal of Pediatrics|May 29, 2007
Rubella infection with autoimmune hemolytic anemiaNeerja Agrawal, Rahul Naithani, M Mahapatra
Hematology, Transfusion and Cell Therapy|September 27, 2024
Bortezomib and low dose venetoclax therapy for relapsed/refractory B-cell acute lymphoblastic leukemia with IDH1 mutationPronamee Borah, Ayoniza Maitri, Rahul Naithani
Journal of Pediatric Hematology/Oncology|October 23, 2015
Successful Use of Eltrombopag in a Child With Hurler Syndrome After Haploidentical Hematopoietic Stem Cell TransplantationRahul Naithani, Mansi Sachdev, Rajiv Uttam
Indian Journal of Pediatrics|May 5, 2009
Pseudotumor cerebri in a child in early phase of induction therapy for APL with ATRARahul Naithani, Rajat Kumar, Pravas Mishra
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 22, 2017
Single Versus Dual Platform Analysis for Hematopoietic Stem Cell Enumeration Using ISHAGE ProtocolRahul Naithani, Nitin Dayal, Gaurav Dixit
South Asian Journal of Cancer|June 17, 2021
Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple MyelomaRahul Naithani, Nitin Dayal, Reeta Rai
Pediatric Blood & Cancer|July 2, 2024
Low-dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe-BIRD) in a child with relapsed/refractory B-cell acute lymphoblastic leukemia with TP53 mutationVivek Mohan, Sachin Jain, Rahul Naithani
European Journal of Haematology|February 8, 2005
Safety of oral iron chelator deferiprone in young thalassaemicsRahul Naithani, Jagdish Chandra, Sharad Sharma
Pediatric Blood & Cancer|February 9, 2008
Does familial predisposition exist in idiopathic thrombocytopenic purpura?Rahul Naithani, Rajat Kumar, M Mahapatra
Pediatric Blood & Cancer|January 6, 2016
T-Cell Acute Lymphoblastic Leukemia, Minimal Residual Disease, and Lymphocyte RecoveryRahul Naithani, Mohammad Abdelhaleem, Angela Punnett
Pageof 12